Establishing the follitropin delta dose that provides a comparable ovarian response to 150 IU/day follitropin alfa-Reference-Cited by-同舟云学术

Establishing the follitropin delta dose that provides a comparable ovarian response to 150 IU/day follitropin alfa

Published:2020-10 Issue:4 Volume:41 Page:616-622
ISSN:1472-6483
Container-title:Reproductive BioMedicine Online
language:en
Short-container-title:Reproductive BioMedicine Online

Author:

Arce Joan-Carles,Larsson Per,García-Velasco Juan Antonio

Publisher

Elsevier BV

Subject

Developmental Biology,Reproductive Medicine,Obstetrics and Gynaecology

Reference13 articles.

1. Revised American Society for Reproductive Medicine classification of endometriosis: 1996;Fertil. Steril.,1997

2. Using AMH for determining a stratified gonadotropin dosing regimen for IVF/ICSI and optimizing outcomes;Arce,2016

3. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection;Arce;Fertil. Steril.,2014

4. Gonal-F. Summary of product characteristics. 2020.https://www.ema.europa.eu/en/documents/product-information/gonal-f-epar-product-information_en.pdf. Accessed 27 May 2020.

5. Rekovelle. Summary of product characteristics. 2020.https://www.ema.europa.eu/en/documents/product-information/rekovelle-epar-product-information_en.pdf. Accessed 27 May 2020.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Follitropin delta combined with menotropin in patients at risk for poor ovarian response during in vitro fertilization cycles: a prospective controlled clinical study;Reproductive Biology and Endocrinology;2024-01-02

2. #263 : Follitropin Delta for Controlled Ovarian Stimulation: Evaluating Dose Equivalence Approach;Fertility & Reproduction;2023-12

3. Follitropin delta combined with menotropin in patients at risk for poor ovarian response during in vitro fertilization cycles: a prospective controlled clinical study;2023-10-23

4. Inadvertent Administration of 72 µg of Follitropin-Δ for Three Consecutive Days Does Not Appear to Be Dangerous for Poor Responders: A Case Series;Journal of Clinical Medicine;2023-08-10

5. Follicle-Stimulating Hormone Biological Products: Does Potency Predict Clinical Efficacy?;International Journal of Molecular Sciences;2023-05-19